April 24, 2012
Senju Pharmaceutical announced on April 20 that it will launch its glaucoma and ocular hypertension treatment Aiphagan ophthalmic solution 0.1% (brimonidine tartrate), positioned as its next strategic product, on May 11. At a new product launch event held in Tokyo,...read more